Supplier
Hartford Hospital
Hartford Hospital was paid $455K by Medicaid between Jan 2018 and Dec 2024, across 15 billing codes. Its largest line is J7503, Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg — 44% of everything it billed.
33Billing provider infoHARTFORD HOSPITAL
HARTFORD, CT 06106
HARTFORD, CT 06106
33aNPI1790183515assigned 12/10/2014
33bProvider typeCommunity/Retail Pharmacy
28Total paid$455K
24GClaims57,476
24DCodes billed15
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Community/Retail Pharmacy providers in Connecticut
Rank by total paid#4 of 125
Median peer was paid$33K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,685 | $42K | |
| 2019 | 10,449 | $76K | |
| 2020 | 8,585 | $34K | |
| 2021 | 9,002 | $59K | |
| 2022 | 10,638 | $110K | |
| 2023 | 6,604 | $53K | |
| 2024incomplete | 5,513 | $81K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | 44% | 3,036 | 1,387 | $202K |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 11% | 10,303 | 4,437 | $50K |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | 9.0% | 1,502 | 1,096 | $41K |
| J7517 | Mycophenolate mofetil, oral, 250 mg | 7.8% | 6,604 | 3,955 | $36K |
| A4670 | Automatic blood pressure monitor | 7.1% | 828 | 828 | $32K |
| A4239 | Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 4.9% | 751 | 599 | $22K |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 4.7% | 10,669 | 6,651 | $21K |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | 3.5% | 17,055 | 5,971 | $16K |
| J7518 | Mycophenolic acid, oral, 180 mg | 2.9% | 577 | 385 | $13K |
| K0553 | Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | 2.0% | 288 | 180 | $9K |
| J7599 | Immunosuppressive drug, not otherwise classified | <1% | 73 | 56 | $4K |
| E0570 | Nebulizer, with compressor | <1% | 76 | 76 | $4K |
3 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKRIESBERG, BARRY (REGIONAL VP OPERATIONS)
Parent organizationHARTFORD HOSPITAL